Amerigo Scientific releases transglutaminase inhibitors designed to advance research into their therapeutic applications across a range of diseases. These transglutaminase inhibitors seek to enable ground-breaking findings in a number of domains, such as autoimmune illnesses, neurological diseases, and cancer research.
“We recognize the urgent need for effective research tools that can shed light on the complex roles of transglutaminases in disease,” said the Chief Scientific Officer at Amerigo Scientific. “Our transglutaminase inhibitors represent a significant step forward in providing researchers the resources they need to uncover novel pathways and potential treatments.”
A family of enzymes known as transglutaminases (TG) is essential for both cellular activity and protein crosslinking. Although these enzymes are necessary for regular physiological functions, studies find several diseases have been linked to their dysregulation. Amerigo Scientific’s transglutaminase inhibitors can serve as pivotal tools for researchers aiming to delineate TG-related mechanisms and explore therapeutic avenues for diseases associated with aberrant transglutaminase activity.
The innovative inhibitors from Amerigo Scientific are characterized by their high specificity and potency. They have undergone rigorous testing to ensure reliability and effectiveness in diverse experimental models, making them indispensable for laboratories focused on advancing our understanding of transglutaminase-related diseases.
In addition to transglutaminase inhibitors, Amerigo Scientific also offers other ubiquitin proteasome products such as ubiquitin / ubiquitin-like proteins and mutants, ubiquitin chains, ubiquitination and deubiquitination enzymes, activators, and subunits. These products are designed to facilitate advanced research in protein degradation pathways, cellular regulation, and the development of therapeutics targeting various diseases related to protein misfolding and aggregation. Furthermore, Amerigo Scientific’s online shop also includes high-quality reagents for studying the mechanisms of ubiquitin signaling, allowing researchers to explore novel insights into cellular processes such as cell cycle regulation, DNA repair, and immune responses. Whether researchers are conducting basic research or developing innovative biopharmaceuticals, Amerigo Scientific is committed to providing the tools necessary to drive their discoveries forward.
